Alkermes plc (ALKS)
NASDAQ: ALKS · Real-Time Price · USD
27.48
-0.07 (-0.25%)
Nov 19, 2024, 4:00 PM EST - Market closed
Alkermes Employees
Alkermes had 2,100 employees as of December 31, 2023. The number of employees decreased by 180 or -7.89% compared to the previous year.
Employees
2,100
Change (1Y)
-180
Growth (1Y)
-7.89%
Revenue / Employee
$716,724
Profits / Employee
$158,736
Market Cap
4.45B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Select Medical Holdings | 54,600 |
Haemonetics | 3,657 |
PROCEPT BioRobotics | 626 |
ADMA Biologics | 624 |
BridgeBio Pharma | 556 |
Axsome Therapeutics | 545 |
Avidity Biosciences | 253 |
Biohaven | 239 |
ALKS News
- 8 days ago - Alkermes to Participate in Two Upcoming Investor Conferences - PRNewsWire
- 12 days ago - Alkermes Highlights Presentations From Across Neuroscience Portfolio at Key Fall 2024 Scientific Conferences - PRNewsWire
- 26 days ago - Alkermes plc (ALKS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 26 days ago - Alkermes plc Reports Third Quarter 2024 Financial Results - PRNewsWire
- 4 weeks ago - Alkermes to Report Third Quarter Financial Results on October 24, 2024 - PRNewsWire
- 7 weeks ago - Alkermes to Host Investor Event to Review Orexin Portfolio Strategy - PRNewsWire
- 2 months ago - Alkermes to Present Positive Clinical Data From Phase 1b Study of ALKS 2680 in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia at Sleep Europe 2024 - PRNewsWire
- 2 months ago - Alkermes Announces Launch of 7th Annual Alkermes Pathways Research Awards® Program - PRNewsWire